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Ths first doable-umbrella devic 
umbrella device for tra~scat~eter closW-e 
arteriosus, teady progress has been 
umbrella closure of congenital nd 
defects. This device has been safely 
children with a host of defects in 
collateral channels, aortopulmonary windows and venous 
connections (34. The recently developed clamshell double 
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is list tc ~~c~~de au-ial 
with these devices and the safest and mo 
vular leaks has not previously been reported. This a 
atients were considered candidates for 
attempted transcatheter closure of a valvular or paravalvujar 
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Table 1. Clinical and H~~nodynamic Findings and Outcome in the Eighi Study Patienis 
PI Ale iyrll Pertinent Hemodynamics 
No Gender Cardiac History Acute Problems Medical History at Catb Device 
Follow-Up 
,.- -.- 
AVR X3; ~d’Xfll&ti Paraaortic leak (Ao- Mediastiniti~ x 1; t&/Q, = 2:l; 2%mm NYlfA CLSS I CBIF 32 1110 Inter I 73/M 
: 12/M 
3 ‘i/M 
4 18/M 
5 51F 
6 ‘l&l 
7 27iiti 
8 13/M 
for CHa 
Surgical repair CCAVC 
x I; MVR x3; AVR 
Xl 
large stroke 
Xl 
Mediastinitis X 1 
RV); Ny!;A class 
IV CHF 
Paraaortic leak (Ao- 
LV): Parznitral 
leak: NYHA class 
IV CHF 
h;-.aoitic leak (A* 
LV); significant V. 
ectapi: activity 
requiring medication 
Paraaortic leak (Ao- 
LV): hemolj:is 
causing damage to 
transph~nted kidney 
Severe AR in a 
Fontan procedux 
candidate. NYHA 
class Ill 
.CI = 2.2; 
PCWp = 30 
PCwp = IS; 
CI = 3 
Rashkind 
12-mm 
Rashkind 
Died at operalion for paramitral 
leak; device found we:! 
seated in paraaortic leak 
Konno repair Wiih 
AVR xi 
None LVEDP = 8; 
Cl = 2.1 
u-mm Well 21 months later: V. 
Rashkind ectoplc activity resolved 
AVR x2; surgical 
repair peraaortic 
leak xl 
Renal transplant LVEDP = 21; 
61 = 3.1 
T&t; hypoplwstic RV 
+ Ao: Stansel repair 
Xl 
Phrenic nerve 
palsy; 
cndocarditis 
xl 
LVEDP = 26; 
CI = 1.7 
Severe regurgitation of 
conduit valve 
2312%mm 
custom- 
made 
clamshell 
device 
23”mm 
Rashkitld 
4 mo Iatcr LVEDP = 18; 6 mo 
later succcsstul bi~~~tcr~l~ 
cavopulmonn-y anastomosis; 
NYHA class 11 
Congenital AS; 
hypoplastic Ao; LV- 
AoDT conduit x I 
Congenitel AS; surgica 
valvotomy x2; AVR 
x I ; LV-AoDT 
conduit XI 
None LtlEDP = 14; 
Cl = 3.3 
Well 47 mo later 
None LVEDP = 28: 
CI = 2.8 
40-mm 
c;amshell 
X2 
2 mo later successful Konno 
repair: well 29 mo later 
Congenital AS; AVR 
x I ; LV-AoDT 
conduit xl 
Severe regurgitation of 
conduit valve; 
NYHA class II 
CHF; recurPent V. 
Tach 
Severe regurgitation of 
conduit va!ve; 
NYHA class IV 
CHF 
None LVEDP = 40; 
Cl = I.4 
23 mm 
Rashkind 
C 40.mm 
clamshell 
Died at attempted Konno repair 
S days later 
Ao = nortn; AoDT = desccndmg aorta; AR = aortic regurgitation; AS = aortic =tc _..*nosis: AVR = aortic valve replacement; Cath = cardiac catheterization; 
CCAVC = common ntrioventricular canal; CHB = complete heart block* . CiiF = congestive heart failure: Cl = cardiac index (literslmin per mZI; F = female: 
LV = IcR ventricle; LVEDP = L.1 ventricular end diastolic prcasure (mm Hg); M = male; MVR = mitral valve replacement; NYNA = New York Heart 
Associ,rtion: PCWp = pulmonary capillary wedge pressure (mm Hg): Pr = patient: Q,,/Q, = pulmonary to systemic flow ratio: RV = right ventricle; Tach = 
tachycardia; TGA = trunsposition of the grea! xteries: V. = ventricular. 
leak only if 1) &sure was indicated for hemodynamic 
reasons, and 2) either the patient was a poor operative 
candidate oradditional surgical treatment was planned and 
the defect could not easily be reached from the same 
operative approach. This determination was made by the 
patient’s cardiologist in conjunction with the cardiac sur- 
geon. Each patient had had two to six prior cardiac opera- 
tions. All patients had at least one of the following medical 
conditions: complex congenital heart disease, history of 
bacterial mediastinitis, history of a large perioperative 
stroke, phrenic nerve palsy, recent renal transplant and 
recu~ent ventricular tachycardia. No patient was refused 
therapy because of unfavorable clinical status. 
Between February 1987 and September 
nts aged 5 to 73 years (median 13) were 
heterization laboratory for closure of a 
valvular or a paravalvular eak. The history, hemodyhlamic 
findings and results of attempted device closure for all of 
these patients are listed in Table 1. 
A parav:lvular leak around a prosthetic ao+ -S4ve was 
present in four of the eight patients. Tbr lebnaining four had 
a valvular leak. One of these f~- ( atient 5) had a regur- 
gitant native aortic valve (this pati t had single ventricle 
and complex congenital heart disease and had undergone 
surgical anastomcOis of the end of the pulmonary artery to 
the side of the atf. ia; the other three patients had a regur- 
gitant porcine valve in a left ventricular apex to descending 
aorta conduit. In the four patients with a paravalvular leak 
and in the one patient whose only hemodynamically signifi- 
cant lesion was a regurgitant left ventricle to descending 
aorta conduit (Patient 61, we hoped that transcatheter um- 
brella placement would eliminate the need for surgical 
intervention i the near future. In the three patients with 
complex lesions and a valvular leak (Patients $7 and B), we 
were performing a palliative proce 
the cardiac operation that each needed in the near future. It 
was the opinion of our surgical colleagues that he transcath- 
eter closure of the defect would markedly simplify the later 
shape and vocation. T 
~~~~ic data can als~ 
be obtained uring balloon cclusi 
e. After we deter 
long sheath was used to eliver 12mm patent ductus arteri- 
osus occluders. An I IF long sheath 
l7-mm, 23-mm, 40-mm and custom-m 
The device was loaded ink the delivery system and placed 
across the defect in the manner previously described (3,6-9). 
ures. All patients received the usual dose of 
00 U/kg body weight) at the beginning of the 
procedure. Anticoag~latio~ was not reversed after the pro- 
cedure. U 
bin before 
the carotid circulation (10). All patients r 
assessment af er defect closure was performed whenever the 
patient’s clinical status permitted. After placement of the 
device, a chest X-ray film was obtained in all eight patients 
in the ventricle (eirrlei. Note the leatlels of Ihe prosthetic aorzic 
valve in the open position during syslole (dose 
ica 
6, 3 and 3 mm in dismeter, res 
appeared tobe symmetric. The 
was crescentic n shape-=-wide 
narrow in another. cause it was believe 
would not lend its to closure with an 
tra~scatheter closure of this defect was not atte 
fistula, had a measurable shunt; the ~~imo~ary to systemic 
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we 2. A, Diagram t>f a symmetrically shaped paravalvular defect 
rca) that would be amenable to transcathcter devke 
Diagram of an asymmetrically shnpccl pmXvi~lvt~lU 
dcfecr (hrtk~ed urea) thM would not be amenable IU transcathetel 
device closure. 
flow ratio was 2:l. In all but one patient the left ventricular 
end-diastolic pressure was clcvatcd More device place- 
ment. 
Test balloon occlusion confirmed the angiographic sizing 
of the paravalvular defects. Unlike ventricular septal defects 
and atrial septal defects (5-7). these lesions were noncom- 
pliant. Surrounded by the rigid sewing ring of the valve and 
firm annular tissue, they stretched very little with balloon 
sizing. For regurgitant valves in left ventricle to descending 
aorta conduits, the test balloon cclusion of the conduit was 
a crucial determinant of whether device closure of the 
regurgitant conduit would be tolerated. The two 12-mm 
conduits were easily occluded with the use of SF’ and 7F 
end-hole balloon-tipped catheters. The 20.mm coryduit re- 
quired a larger balloon diameter fo occlusion (Meditech 
occlusion balloon catheter 27181100). In each of these cases 
the conduit had been placed originally because of severe 
aortic valve and anulus tenosis. To evaluate whether con- 
duit occlusion was hemodynamically tolerated, we measured 
the aortic valve gradient, left ventricular end-d:astolic pres- 
sure and thermodilution cardiac output at rest and during 
balloon occlusion. After occlusion of the conduit, Patient 6 
had a M-mm gradieut across his native aortic valve and 
Patients 7 and 8 had a 60-mm gradient. In each case, balloon 
occlusion brought about either a decrease inor no change in 
left ventricular end-diastolic pressure and an increase or no 
change in the cardiac index. 
Catheter approach. As the location of the defect in these 
eight patients varied, so did the catheter approach. 
Patient 1. The paraaortic fistula was between the aorta 
and the right ventricle. It was approached in a manner 
analogous tothat of the double-catheter approach described 
previously for transcatheler closure of ventricular septal 
defects (7). The defect was crossed with an end-hole balloon- 
tipped catheter from the aotia. A long guide wire was 
advanced through this catheter into the right ventricle and 
out into the inferior vena cava. The venous end of the wire 
was then snared and externalized through the femoral 
Figrc 3. ~lil(l~~n tiU?l~O$t~lde Ofa conduit after device ~~~~~~Cllt to
promote stasis and clotting. Note that two clamshell devices While 
arrows) iltld multiple coils (MN ) were rcqluired for 
closure ofthis conduit. 
ve;lous sheath. The defect was then bal aon sized and the 
device was delivered by the venous route. 
Patierrts 2. 3 md 4. Each of these patients had a para- 
valvular leak around aprosthetic aortic valve connecting the 
ntricle. All three defects were approached 
on and crossed from the aorta with a 0.03 
. This wire was exchanged for a 0.03 
exchange wire with a large curve. Iloon 
si.zing and device delive rmed over thi ire. 
Pcctiertt 5. The regurgitant ative aortic valve in this 
patient was app hed from the ascending aorta. A 7F 
erld-hole b&on-ti ed catheter was advanced easily across 
the valve when the balloon was inflated. An exchange wire 
was then advanced into the single ventricle through that 
catheter, and over this we attempted device delivery. 
Patients 6, 7 and 8. Each of these patients had a left 
ventricle to descending aorta conduit with a regurgitant 
porcine valve. In each case the conduit was entered from the 
descending aorta with t e use of an end-hole b,,“oon-tipped 
catheter. After balloon occlusion this catheter was ex- 
changed over a wire for a long sheath for device delivery. 
Catheter closure technique. Qf the eight patients taken to 
the catheterization laboratory for possible device closure of 
a valvular or paravalvular leak, seven underwent a tempted 
device placement. One device was required for closure in 
five patients, and more than one d vice was required in tke 
other two. Both of these latter patients had  left ventricle to 
descending aorta conduit. In each there was free flow 
through the conduit after a first and a second evice were 
placed, and flow was not occluded until a series of coils had 
been packed between the two devices and the distal end of 
the conduit had been balloon tamponaded for10 to 30 min to 
promote stasis and clotting (Fig. 3). 
In all, nine double-umbrella devices were placed across 
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femora8 artery up into the Ml 
of this catheter was then inflated a 
was positioned across the aortic valve. 
ductus arteriosus 
graphically evaluate our 
renal failure. Wsing oxim 
in the pulmonary to syste 
Angiography demonstrated that he defects causing the other 
two ~aravalv~~ar le ks were completely occluded (Fig. 4) 
and that, of the four patients with attenuated closure of a 
valvular kak, one had a complete& occluded conduit, two 
had trivial residual flow and one had mild residual flow past 
the device in the native aortic valve. 
Follow-up transthoracic echocardiography waq per- 
formed in four of the seven patients who received an 
umbrella device. One of these four studies was technically 
limited because of poor echocardiographic w ndows. The 
other three studies confirmed the degree of residual leak that 
seen angiographically after device 
icaG~~s, All significant corn 
When this 70 year old man first left the catheter- 
horatory, he had a significant residklal leak across a
askkind evice that was in place across an aorta to 
right ventricle fistula. Over the next few hours, oiiguria 
developed and hemolysis that was presumably due to the 
residual Rqw through or around the device. The device 
migrated tL:he pulmonary artery 12 h later as demonstrated 
Aortic root injection slem0nstrating paravalvul 
of contrast medium (arrsw) regurgitating into 
Same patient after device placement hrr 
m chest X-ray film, and the hemolysis imme 
solved. The patient was returned to the cat 
laboratory where a second, %3-mm, device 
incorrectly, slightly elow the level of the prosthetic aortic 
valve. This umbrell immediately embolized to the pulmo- 
nary artery. Finally, a third, 2%mm, device was s~ccess~~~~y 
placed across the t. The two errant 
retrieved from the orrary artery with a 
catheter and were removed from the femora 
down procedure. This patient’s renal function significantly 
improved over the next 7 days as did Ris hemodynamic 
status. 
d in twa patients. 
therapy for 36 h (11). There were no other early 
tions. SpecificaNy, there were no known stroke 
cnibcli,: p!EnomerIP, arrhyM?ias 0: I3fertio 
we evaluated (Patients to 
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failure class IV to class I and is well 32 months after device 
placement. Patient 2 was clinically unchanged after closure 
of a pamaortic leak and died after aortic va!ve rep!acement 
and attempted surgical repair of aparamitral ieak. Had we 
known that the paramitral leak contributed substantially to 
the congestive heart failure and hemolysis, we would not 
have attempted closure of the paraaortic leak. In the oper- 
ating room the umbrel!a device was found well seated across 
his defect. Patient 3is asymptomatic 21months after &ViCe 
placement. The ventricular ectopic activity that, before 
device placement, consrsted offrequent couplets and triplets 
despite antiarrhythmic therapy, resolved within 6 months, 
and he currently requires no antiarrhythmic medication. 
Patient 4, who did not undergo device closure because ofthe 
cresccntic shape of the defect, died at attempted surgical 
repair. 
Of the four patients whose valvular leak we closed 
(Patients 5 to 8), Patient 5 had a decrease in ventricular 
end-diastolic pressure from 24 mm before device place- 
ment o 18 mm Wg 4 months later evice closure of the 
native aortic valve apparently relie some of the volume 
load on this patient’s ingle ventricle and the improved 
ventricular function allowed her to undergo a successful 
bilateral cavopulmonary anastomosis 6 months after place- 
ment of the device. At that operation the device was found 
centrally located in the valve. The media! arms on the left 
ventricular side were embedded deep into the muscle of the 
septum, preventing this side of the device from sitting snugly 
under the valve and causing the small residual leak that had 
been seen angiographically. The device was removed and 
the aortic valve was closed surgically. She is well 29 months 
after initial device placement. Patient 6 was we!! before 
device placement and remains well 4 years later. The con- 
dition of Patients 7 and 8 was unchanged after conduit 
occlusion. In these two pattents our goal was not clinical 
improvement; each required extensive surgical reconstruc- 
tion of a left ventricular outflow tract and we and the 
patients’ urgeons felt certain that prior occlusion of the left 
ventricle to descending aorta conduit would markedly sim- 
plify this procedure. Patient 7 did undergo a successful 
Konno operation (enlargement of the aortic root and aortic 
valve replacement) 2 months later and isnow well at home 
29 months after device placement. Patient 8 died at at- 
ted Konno procedure 2 days after device placement, 
There have been u known late complications such as 
stroke, infection. arrhythmia or prosthetic valve dysfunc- 
tion. 
We have described a method of transcatheter umbrella 
closure Of a variety of paravalvular nd valvular leaks. 
Although these procedures were successful in seven cases, 
and produced lasting clinical improvement i  five, severa! 
points shoutd be made r garding our results. 
~om~~icatio~s. Of the seven patients who received a 
device, two (Patients 4 and 8) died, both during surgical 
repair of an associated defect and wit 
to umbrella closure. The paraaortic 
closed by the 12,.mm device in Patient 4, but 
attempted surgical repair of a hemo 
paramitra! leak. At operation, the paraaortic leak appeare 
to be closed by a well seated evice, and it does not appear 
that closure of this leak coutr~buted to the patient’s death 
Patient $ presented to the hospital after an interva! of 
several years in India when he could n 
had severe congestive heart failure w 
end-diastolic pressure of 2 
the catheterization labor 
balloon occlusion of the 
his cardiac index, there was ni change in left ventricular 
end-diastolic pressure and there was a 60- 
across the native aortic valve. It is likely that 
leaking conduit raded a Jolume load for a pressure load on
the left ventricle but did not produce nougk bemody~a~lic 
improvement to alter an inexorably clinical decline. He was 
taken for surgical reconstruction 
flow tract 2 days later and died i 
molysis was a complication 
patient (Patient !); it resolved o 
and did not recur when a large 
This patient’s defect was a p 
aorta and the right ventricle. It seems that hemolysis oc- 
curred because there was significant .esidual f ow through or 
around this device and a large pressu 
Thus, the regurgitating blood was pro 
causing hemolysis. We recommend c 
patients for signs of hemolysis whenever a defect with a high 
pressure gradient across it is incompletely closed by a device 
and there is significant residual fi~w through the device. 
Dake rwjption occurred twice in one patient vi& a 
paraaortic leak and not in any other patient. It seems that  
high pressure gradient across a defect can also increase the 
risk of migration of a device placed across it. A device 
placed in a defect with a high pressure gradient across it 
should be somewhat larger than what one would normally 
choose for that sized defect. 
Se~~~fun~~ valveclosure. The clinical need for device 
closure of a native semilunar valve should not arise very 
frequently. We cannot conclude from our experience with 
this one patient (Patient 5) whether the device as currently 
designed wi!! be effective inthis location. We can only report 
that in this one case where device placement contributed 
significantly to the patient’s eventual successful surgical 
outcome, the device did not fit snugly under the valve and 
m risk of bacteri-! endocarditis 
after double-umbrella p cement is not know 
Echocardiographic evaluation. Because of the shadowing 
produced by prosthetic valves, transthoracic e hocardiog- 
raphy was not helpful in defining the anatomy of these leaks. 
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